Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Current Liabilities

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Current Liabilities ₹455 Cr₹327 Cr₹269 Cr₹209 Cr

What is the latest Total Current Liabilities ratio of CORONA REMEDIES ?

The latest Total Current Liabilities ratio of CORONA REMEDIES is ₹455 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹455 Cr
Mar2025₹327 Cr
Mar2024₹269 Cr
Mar2023₹209 Cr

How is Total Current Liabilities of CORONA REMEDIES Trending?

Years Total Current Liabilities % Change
Mar2026 ₹455 Cr
38.96
Mar2025 ₹327 Cr
21.68
Mar2024 ₹269 Cr
28.46
Mar2023 ₹209 Cr -

Compare Total Current Liabilities of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,423.3 Cr -4% -0.6% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-4%

-0.6%

NA
SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses